ong term follow up after transurethral treatment of infravesical obstruction in boys
Completed
- Conditions
- narrowing of the urethraurethral obstruction10046447
- Registration Number
- NL-OMON38383
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
Male sex
Age > 18 years
Transurethral treatment of infravesical obstruction between January 1986 and December 2010
Willing and able to participate in the study
• Signed informed consent
Exclusion Criteria
Neurogenic bladder disorder
Congenital anomaly of the penis, like hypospadias or epispadias
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>IPSS, urinary tract infections episodes, incontinence episodes, uroflowmetry,<br /><br>post void residual </p><br>
- Secondary Outcome Measures
Name Time Method <p>Micturition diary, retrograde ejaculation, coping style</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms contribute to urethral obstruction recurrence after transurethral treatment in boys (NL-OMON38383)?
How does transurethral treatment compare to endoscopic surgery for long-term management of infravesical obstruction in pediatric males?
Which biomarkers predict successful long-term outcomes in NL-OMON38383 transurethral treatment for urethral obstruction in boys?
What are the long-term safety profiles and management strategies for transurethral infravesical obstruction treatment in boys?
Are there novel therapeutic approaches or adjuncts to transurethral treatment for pediatric infravesical obstruction (UMC Utrecht)?